With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Novel Resilience Genes Required for Cerebellum Development and Medulloblastoma Survival||University of California San Francisco / Stephen Fancy, PhD, DVM||Innovation Grants||2023||California|
|Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS||St. Jude Children's Research Hospital / Dirk Loeffler, PhD||RUNX1 Early Career Investigator Grants||2023||Tennessee|
|Identifying Ewing Sarcoma Developmental Vulnerabilities||Children's Hospital Los Angeles / Elena Vasileva, PhD||Young Investigator Grants||2023||California|
|CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma||Dana-Farber Cancer Institute / Susu Zhang, PhD||Young Investigator Grants||2023||Massachusetts|
|Radiation and the Tumor Microenvironment in an Immunocompetent Model of Ewing Sarcoma||Children's Hospital of Pittsburgh Foundation / Jessica Daley, MD||Young Investigator Grants||2023||Pennsylvania|
|Targeting the biological underpinnings of pulmonary metastasis in osteosarcoma||Dana-Farber Cancer Institute / Rani George, MD/PhD||Crazy 8 Awards||2022||Massachusetts|
|GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma||Baylor College of Medicine / Kyle Eagen, PhD||R Accelerated Award Grants||2022||Texas|
|Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL||Temple University / Christian Hurtz, PhD||'A' Award Grants||2022||Pennsylvania|
|Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations||The Regents of the University of Michigan / Jolanta Grembecka, PhD||Reach Grants||2022||Michigan|
|Inhibition of translation initiation as a novel therapeutic strategy against MYCN-amplified neuroblastoma||Dana-Farber Cancer Institute / Rani George, MD, PhD||Innovation Grants||2022||Massachusetts|